VCAN and leiomyoma: Human myometrial and leiomyoma cells were treated with nintedanib at 5 μM for 24 h, and mRNA and protein levels of fibrosis‐related molecules (fibronectin and versican) were measured by real time qPCR and western blot, respectively.